A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...

Medical professionals call for structured, science-based care and compassion in tackling this health condition.

Noticing a receding hairline? You’re not alone — and thanks to years of research, effective treatments are within reach. Male ...

Objectives To evaluate whether type 2 diabetes mellitus (T2DM) presence and severity are associated with differences in global and domain-specific cognitive function among US adults, using ...

The Alzheimer’s field is being turned on its head as mounting evidence points to the disease beginning outside the brain many ...

A study published in the Journal of Veterinary Pharmacology and Therapeutics on Feb. 7, 2026, has quantified the amount of ...

A new report finds women lost an average of 10.9% body weight vs. 6.8% for men on GLP-1 drugs. Dr. Todd Ellerin of South Shore Health explains possible reasons and next steps for men.

Thinking about GLP-1 meds? A Hy-Vee dietitian explains how to eat to protect muscle, energy and digestion when your appetite drops.

Meta-analysis of 64 clinical trials 'should give clinicians and their patients more confidence,' say Hopkins researchers ...

Regardless of whether you have diabetes or not, you’re going to feel the effects of a spike in your blood sugar levels. For ...

Among six trials that analyzed outcomes for nearly 20,000 participants by sex, women lost an average of 10.88% (95% CI -14.76 to -7) of their baseline body weight on a GLP-1 agent, while men lost 6.8% ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...